Published in JAMA on May 05, 1962
The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency. Bull World Health Organ (1966) 1.54
G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol (2013) 1.53
Associations between red cell glucose-6-phosphate dehydrogenase variants and vascular diseases. Am J Hum Genet (1967) 1.10
ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN CHINESE. Br Med J (1964) 1.07
Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia. PLoS One (2014) 1.06
Distribution and heredity of erythrocyte G6PD activity and electrophoretic variants among different racial groups at São Paulo, Brazil. J Med Genet (1969) 1.06
Evidence for four types of erythrocyte glucose-6-phosphate dehydrogenase from G-6-PD-deficient human subjects. J Clin Invest (1966) 1.02
Glucose-6-phosphate dehydrogenase deficiency in an endemic area for malaria in Manaus: a cross-sectional survey in the Brazilian Amazon. PLoS One (2009) 1.01
Acute viral hepatitis, intravascular haemolysis, severe hyperbilirubinaemia and renal failure in glucose-6-phosphate dehydrogenase deficient patients. Postgrad Med J (1985) 0.99
Molecular characterization of glucose-6-phosphate dehydrogenase deficient variants in Baghdad city - Iraq. BMC Blood Disord (2012) 0.98
Double heterozygosity for glucose-6-phosphate dehydrogenase deficiency. J Med Genet (1971) 0.96
Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks. Vox Sang (2013) 0.96
Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency. Malar J (2013) 0.93
A NEW INHERITED ENZYMATIC DEFICIENCY OF HUMAN ERYTHROCYTES: 6-PHOSPHOGLUCONATE DEHYDROGENASE DEFICIENCY. Am J Hum Genet (1964) 0.91
RED CELL GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY--A NEWLY RECOGNIZED CAUSE OF NEONATAL JAUNDICE AND KERNICTERUS IN CANADA. Can Med Assoc J (1964) 0.90
Studies on thalassemia, glucose-6-phosphate dehydrogenase deficiency, and sickle cell trait in the Province of Huelva (Spain). Am J Hum Genet (1969) 0.89
Hereditary hemolytic anemias associated with specific erythrocyte enzymopathies. Calif Med (1968) 0.89
Thalassemia and G-6-PD deficiency in Chinese-Canadians: admission screening of a hospital population. Can Med Assoc J (1971) 0.87
Prevalence and molecular characterization of Glucose-6-Phosphate dehydrogenase deficient variants among the Kurdish population of Northern Iraq. BMC Blood Disord (2010) 0.84
Glucose-6-phosphate dehydrogenase deficiency in Chinese. J Clin Pathol (1968) 0.78
Evaluation of antimalarial activity and toxicity of a new primaquine prodrug. PLoS One (2014) 0.78
PharmGKB summary: methylene blue pathway. Pharmacogenet Genomics (2013) 0.78
Glucose-6-phosphate dehydrogenase activity in erythrocytes of experimental animals. J Clin Pathol (1966) 0.75
Inherited anaemias in the Greek community of Cape Town. J Med Genet (1979) 0.75
Sub-Saharan red cell antigen phenotypes and glucose-6-phosphate dehydrogenase deficiency variants in French Guiana. Malar J (2016) 0.75
Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka. PLoS One (2017) 0.75
Glucose 6-phosphate dehydrogenase deficiency in Muslim community settled in Jaunpur district. Indian J Hum Genet (2014) 0.75
Enzymatic deficiency in primaquine-sensitive erythrocytes. Science (1956) 5.39
The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes. J Lab Clin Med (1955) 2.63
Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance. Arch Intern Med (1962) 2.52
Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report. Bull World Health Organ (1960) 2.50
Methaemoglobin reduction test: a new, simple, in vitro test for identifying primaquine-sensitivity. Bull World Health Organ (1960) 2.28
THE BETA-GALACTOSIDE PERMEASE SYSTEM AND THE METABOLISM OF PHOSPHOLIPIDS IN ESCHERICHIA COLI. J Biol Chem (1965) 2.25
Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. J Natl Malar Soc (1950) 1.79
Korean vivax malaria. III. Curative effect and toxicity of primaquine in doses from 10 to 30 mg. daily. Am J Trop Med Hyg (1953) 1.79
Korean vivax malaria. I. Natural history and response to chloroquine. Am J Trop Med Hyg (1953) 1.75
Toxicity of primaquine in Caucasians. J Am Med Assoc (1952) 1.74
Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis. JAMA (1962) 1.71
The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character. J Lab Clin Med (1954) 1.67
Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am J Trop Med Hyg (1953) 1.66
Toxicity of primaquine in Negroes. J Am Med Assoc (1952) 1.63
Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. J Lab Clin Med (1955) 1.55
The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis. J Lab Clin Med (1954) 1.50
STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM THAILAND. Bull World Health Organ (1964) 1.48
ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE IN CAUCASIANS: NEW INHERITED VARIANT. Science (1964) 1.41
The hemolytic effect of primaquine. VI. An in vitro test for sensitivity of erythrocytes to primaquine. J Lab Clin Med (1955) 1.37
Mass therapy of subclinical vivax malaria with primaquine. J Am Med Assoc (1952) 1.35
Korean vivax malaria. II. Curative treatment with pamaquine and primaquine. Am J Trop Med Hyg (1953) 1.35
The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaquine-sensitive individuals. J Lab Clin Med (1954) 1.33
Biochemical and genetic aspects of primaquine-sensitive hemolytic anemia. Ann Intern Med (1958) 1.28
Cure of Korean vivax malaria with pamaquine and primaquine. J Am Med Assoc (1952) 1.27
The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain). J Lab Clin Med (1955) 1.25
STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM COLOMBIA, SOUTH AMERICA. Am J Trop Med Hyg (1963) 1.24
The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity. J Lab Clin Med (1955) 1.23
The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes. J Lab Clin Med (1954) 1.22
The influence of dietary protein intake on specific renal functions in normal man. J Lab Clin Med (1954) 1.21
The hemolytic effect of primaquine. VIII. The effect of drug administration on parameters of primaquine sensitivity. J Lab Clin Med (1958) 1.12
The hemolytic effect of primaquine. XIII. Gradient susceptibility to hemolysis of primaquine-sensitive erythrocytes. J Lab Clin Med (1961) 1.09
STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM VIET-NAM. Bull World Health Organ (1964) 1.07
The hemolytic effect of primaquine. IX. Enzymatic abnormalities in primaquine-sensitive erythrocytes. J Lab Clin Med (1958) 1.06
Natural history of Korean vivax malaria after deliberate inoculation of human volunteers. J Lab Clin Med (1954) 1.03
The hemolytic effect of primaquine. XI. Decreased catalase activity in primaquine-sensitive erythrocytes. J Lab Clin Med (1961) 1.02
The Chesson strain of Plasmodium vivax malaria; relationship between prepatent period, latent period and relapse rate. J Infect Dis (1947) 1.00
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND FALCIPARUM MALARIA. Am J Trop Med Hyg (1965) 1.00
A clinical study of primaquine (S. N. 13,272) in the treatment of malaria among the Miskito Indians of Nicaragua. Am J Trop Med Hyg (1953) 0.98
Induced primaquine resistance in vivax malaria. Trans R Soc Trop Med Hyg (1961) 0.95
Biochemistry of hemolysis. Annu Rev Med (1962) 0.93
Korean vivax malaria. IV. Curative effect of 15 milligrams of primaquine daily for 7 days. Am J Trop Med Hyg (1953) 0.93
The effect of continuous and intermittent primaquine therapy on the relapse rate of Chesson strain vivax malaria. J Lab Clin Med (1954) 0.92
Coenzyme studies in primaquine-sensitive erythrocytes. Proc Soc Exp Biol Med (1958) 0.92
STUDIES ON THE CORRELATION OF THE GENETICALLY DETERMINED TRAIT, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, WITH BEHAVIORAL MANIFESTATIONS IN SCHIZOPHRENIA. J Lab Clin Med (1963) 0.91
A NEW INHERITED ENZYMATIC DEFICIENCY OF HUMAN ERYTHROCYTES: 6-PHOSPHOGLUCONATE DEHYDROGENASE DEFICIENCY. Am J Hum Genet (1964) 0.91
A NEW INHERITED ABNORMALITY OF HUMAN ERYTHROCYTES: ELEVATED ERYTHROCYTIC ADENOSINE TRIPHOSPHATE. Biochem Biophys Res Commun (1965) 0.89
The hemolytic effect of primaquine. XV. Role of methemoglobin. J Lab Clin Med (1962) 0.89
HEMOLYTIC EFFECT OF PRIMAQUINE. XVII. HEXOKINASE ACTIVITY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT AND NORMAL ERYTHROCYTES. J Lab Clin Med (1964) 0.85
Glucose-6-phosphate dehydrogenase deficiency: some biological implications. Trans Assoc Am Physicians (1960) 0.85
The concurrent weekly administration of chloroquine and primaquine for the prevention of Korean vivax malaria. Bull World Health Organ (1961) 0.84
The hemolytic effect of primaquine. X. Aldolase and glyceraldehyde-3-phosphate dehydrogenase activity in primaquine-sensitive erythrocytes. J Lab Clin Med (1959) 0.81
Physiological changes during perfusion of the isolated intestinal loop in chronic uremia. J Lab Clin Med (1952) 0.81
The hemolytic effect of primaquine. XIV. Pentose metabolism in primaquine-sensitive erythrocytes. J Lab Clin Med (1961) 0.81
A RE-EVALUATION OF THE RELATIONSHIP BETWEEN GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND THE BEHAVIORAL MANIFESTATIONS OF SCHIZOPHRENIA. J Lab Clin Med (1965) 0.78
A method of determining the specific renal functions of glomerular filtration, maximal tubular excretion (or reabsorption) and effective blood flow using a single injection of a single substance. J Lab Clin Med (1947) 0.78
HEXOKINASE ACTIVITY AS A FUNCTION OF AGE OF THE HUMAN ERYTHROCYTE. Nature (1963) 0.77
Subclinical diabetes mellitus in patients presenting with clinical chronic glomerulonephritis. Trans Assoc Am Physicians (1958) 0.76
Pentaquine (SN-13,276) a new antimalarial effective in reducing the relapse rate of vivax malaria. Proc Annu Meet Cent Soc Clin Res U S (1947) 0.75
Renal resistance in essential hypertension; relation to the effect of sympathectomy on blood pressure. Proc Soc Exp Biol Med (1948) 0.75
Malignant hypertension. Med Clin North Am (1951) 0.75
Toxicity studies of pyrimethamine (daraprim). Am J Trop Med Hyg (1955) 0.75
Procedures used at Stateville penitentiary for the testing of potential antimalarial agents. J Clin Invest (1948) 0.75
The clinical trial of 18 analogues of pamaquin (plasmochin) in vivax malaria, Chesson strain. J Clin Invest (1948) 0.75
[Phosphoglycerylaldehyde dehydrogenase activity in aging human erythrocytes]. Klin Wochenschr (1963) 0.75
A clinical method of determining the specific renal functions of glomerular filtration and maximal tubular excretion, or reabsorption (and effective blood flow), using a single injection of a single substance. J Lab Clin Med (1946) 0.75
A clinical method of determining the specific renal functions of glomerular filtration, maximal tubular excretion or reabsorption (and effective blood flow) using a single injection of a single substance. Proc Annu Meet Cent Soc Clin Res U S (1945) 0.75
The relation of renal to non-renal vascular resistances in essential hypertension; and the effect of sympathectomy. J Clin Invest (1948) 0.75
Pentaquine (SN-13,276) a therapeutic agent effective in reducing the relapse rate in vivax malaria. J Clin Invest (1948) 0.75
A review of the best new antimalarial drugs. Whats New (1950) 0.75
Studies on the chronic toxicity of chloroquine (SN-7618). J Clin Invest (1948) 0.75
Alterations of cerebral functions in pheochromocytoma. Neurology (1951) 0.75
Study of pentaquine and isopentaquine, therapeutic agents effective in reducing relapse rate in vivax malaria. Abstr Int Congr Trop Med Malar (1948) 0.75
A study of the prophylactic, curative and suppressive activity of SN-11,437 (metachloridine) in standardized infections of vivax malaria. Am J Trop Med Hyg (1948) 0.75
A clinical test for galactosemia. The galactose-methemoglobin test. Am J Clin Pathol (1963) 0.75
HEMOLYTIC EFFECT OF PRIMAQUINE. XVI. GLYOXALASE ACTIVITY OF PRIMAQUINE-SENSITIVE AND NORMAL ERYTHROCYTES. J Lab Clin Med (1964) 0.75
ACTIVE IMMUNIZATION AGAINST MALARIA. Am J Trop Med Hyg (1964) 0.75